MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan · Delayed Price · Currency is TWD 6.15
+0.01 (0.16%)
Feb 11, 2026, 2:59 PM CST
MARX Biotech Market Cap
MARX Biotech has a market cap or net worth of 3.11 billion as of February 13, 2026. Its market cap has decreased by -9.43% in one year.
Market Cap
3.11B
Enterprise Value
3.46B
Revenue
712.87M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.15
Market Cap Chart
Since February 5, 2024, MARX Biotech's market cap has decreased from 4.38B to 3.11B, a decrease of -29.00%. That is a compound annual growth rate of -15.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 3.11B | 27.59% |
| Dec 31, 2025 | 2.44B | -30.65% |
| Dec 31, 2024 | 3.52B | -19.77% |
| Feb 5, 2024 | 4.38B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 268.14B |
| Caliway Biopharmaceuticals | 248.00B |
| Lotus Pharmaceutical | 76.92B |
| Heron Neutron Medical | 74.10B |
| Medimaging Integrated Solution | 3.25B |
| 3D Global Biotech | 3.23B |
| WeLeader Biomedical | 3.23B |
| ShareHope Medicine | 3.21B |